What Is the Treatment of Medial Medullary Syndrome?
Medial medullary syndrome is an ischaemic brainstem infarction involving the medial medulla oblongata. The acute presentation requires prompt, evidence-based intervention to limit neurological injury and guide recovery.
Treatment Approach
First-line management is initiated orally in the acute post-stroke period. The protocol specifies which agent to use, the appropriate starting dose, and the critical administration window after onset.
References
DOI: 10.1161/STR.0b013e318284056a
Oral administration of aspirin (initial dose is 325 mg) within 24 to 48 hours after stroke onset is recommended for treatment of most patients (Class I; Level of Evidence A).
View source ↗